| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6093867 | Gastroenterology | 2015 | 16 Pages |
Abstract
Based on a network meta-analysis, adalimumab and infliximab + azathioprine are the most effective therapies for induction and maintenance of remission of Crohn's disease.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Glen S. Hazlewood, Ali Rezaie, Meredith Borman, Remo Panaccione, Subrata Ghosh, Cynthia H. Seow, Ellen Kuenzig, George Tomlinson, Corey A. Siegel, Gil Y. Melmed, Gilaad G. Kaplan,